PATIENTS WITH ? 20 X 109/L PLATELETS AT BASELINE MAY HAVE A PROMPT RESPONSE TO ROMIPLOSTIM DURING THE EARLY PHASE OF TREATMENT: AN ITALIAN SINGLE-INSTITUTION EXPERIENCE. (2012). Mediterranean Journal of Hematology and Infectious Diseases, 4(1), e2012044. https://doi.org/10.4084/mjhid.2012.044